Impact of assay parameters on the accuracy of free PSA test: source and stability of calibrator, calibration curve fitting, and level of total PSA in the serum.

J Clin Lab Anal

Department of Pathology and Associated Regional University Pathologists, University of Utah Health Science Complex, Salt Lake City 84132, USA.

Published: December 1998

The measurement of PSA is recommended for men over 50 years of age for screening of prostate cancer. However, proper differentiation of prostate cancer from benign prostate hyperplasia (BPH) relies on an accurate measurement of free PSA (fPSA) and a correct calculation of percent fPSA. Because of the extremely low concentration of fPSA in the serum, any slight deviation from its true value may produce large errors in percent fPSA calculated. Therefore, we undertook a study examining carefully those parameters of the fPSA assay which might affect the fPSA determination. We found that the integrity of the calibrator, the computer curve-fitting program selected, the source of the calibrator, and the total PSA or fPSA + PSA complexes (tPSA) concentration of the specimen all had an impact on the accuracy of the fPSA value assayed. We found that an examination of the slope of the calibration curve was important to reveal whether the calibrator had or had not been denatured during storage. We also found that the 4-parameter cure fitting program was best suited for plotting the fPSA calibration curve. The calibrator we isolated from LNCaP cells was acceptable for our assay because it had an affinity for the assay antibody very similar to that of serum fPSA. We also determined the effect of tPSA concentration on the fPSA determinations and found that within the concentration range of 4-10 ng/mL the impact on the percent fPSA calculated was not significant. We believe that our assay produces accurate fPSA values when all these assay parameters are well controlled.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807898PMC
http://dx.doi.org/10.1002/(SICI)1098-2825(1998)12:5<304::AID-JCLA10>3.0.CO;2-ZDOI Listing

Publication Analysis

Top Keywords

fpsa
13
calibration curve
12
percent fpsa
12
assay parameters
8
free psa
8
total psa
8
prostate cancer
8
psa fpsa
8
concentration fpsa
8
fpsa calculated
8

Similar Publications

Background: To assess the clinical utility of PCA3 in the diagnostic accuracy, the correlation between PCA3 and biopsy or pathological characteristics and the performance of PCA3 to reduce the unnecessary biopsies in Chinese population.

Methods: A prospective study including patients with indication of prostate biopsies from 4 centers was conducted. All patients underwent PCA3 urine tests and prostate biopsies.

View Article and Find Full Text PDF

Aim: Prostate cancer (PCa) is a common malignant tumor in men. This study aimed to explore the predictive value of serum biomarkers combined with ultrasound parameters for postoperative Gleason grading in PCa.

Methods: This study included 65 PCa patients who underwent transurethral resection of the prostate in our hospital from January 2021 to December 2023.

View Article and Find Full Text PDF

Dual-Enhanced SERS Satellite Immuno-Nanocomplex for Multiple PSA-Mediated PHI Assay Toward Clinical Prostate Cancer Screening.

Adv Sci (Weinh)

December 2024

Institute for Safflower Industry Research, Key Laboratory of Xinjiang Phytomedicine Resource and Utilization (Ministry of Education), School of Pharmacy, Shihezi University, Shihezi, 832003, China.

Prostate specific antigen (PSA) is widely used in liquid biopsy of prostate cancer (PCa) but still faces challenges due to the poor specificity. Herein, this study reports a double-SERS satellite immunoassay, made of an Au-Ag dealloyed intra-nanogap nanoflower (Au-Ag DINF) with strong SERS signals and Au magnetic nanoparticles (AuMNPs) with magnetic capture and SERS amplification, for sensing multiple PSA (free PSA (fPSA), complexed PSA (cPSA) and [-2]proPSA (p2PSA)) toward potential PCa screening. Unlike the previous studies focus on the tPSA and fPSA/tPSA ratio (f/t PSA%), this work introduces a multiple PSA-mediated Prostate Health Index (PHI) assay with significantly increased the predictive accuracy and specificity of PCa, especially the patients with a tPSA level in the "diagnostic gray zone".

View Article and Find Full Text PDF

Background: Prostate cancer manifests in various forms, ranging from occult and localized to metastatic disease. Analyzing prostate biopsies offers insights into histopathological characteristics, enhancing disease understanding and management.

Methods: This 14-year study reviewed ultrasound-guided needle prostate biopsies, collecting data via questionnaires and medical records, focusing on Gleason group, tumor involvement percentage, and predicted cancer stage.

View Article and Find Full Text PDF

Background: Traditional diagnostic methods have limitations in accurately identifying and characterising prostate apex cancer. Therefore, exploring innovative approaches such as magnetic resonance imaging (MRI) radiomics, biomarker assessments and clinical pathological features is essential to improve diagnostic accuracy.

Methods: This retrospective study evaluated diagnostic data from 52 patients with prostate apex cancer and 52 healthy individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!